steve broadbent - why is c-path so important in the regulatory science area?
Published 4 years ago • 21 plays • Length 0:43Download video MP4
Download video MP3
Similar videos
-
0:36
steve broadbent - why is data sharing important?
-
0:43
steve broadbent - what work is pkdoc doing in pharmacometric models?
-
0:56
steve broadbent - what has c-path done to accelerate therapies for pkd?
-
0:51
steve broadbent - what are pharmacometric models?
-
1:05:35
risk-controlling prediction sets (stephen bates, discussion by vladimir vovk)
-
55:34
stefano castruccio - calibration of spatial forecasts from citizen science urban air pollution data
-
31:37
andreas krause (eth zuerich): "safe exploration in reinforcement learning"
-
1:49
steve broadbent - what is a reasonably likely surrogate? what is its use in pkd drug development?
-
0:40
steve broadbent - what is pkdoc doing in data sharing?
-
1:02
steve broadbent - how has qualifying total kidney volume helped in pkd therapy development?
-
2:14
martha brumfield - what is c-path's purpose and history?
-
1:59
jane larkindale - what is c-path doing that is unique in drug development for rare disease?
-
2:16
klaus romero - what does c-path do?
-
1:35:26
2022 pro consortium workshop: use and interpretation of meaningful within-person change thresholds
-
1:29
diane stephenson - how does cpp integrate the voice of the patient?
-
21:29
2022 rdca-dap workshop: case study 4: friedreich’s ataxia (fa) modeling project
-
3:14
stephen coons - what type of clinical outcomes does the pro consortium focus on?
-
4:07
rss 2021, spotlight talk 77: inferring objectives in continuous dynamic games from noise...
-
48:00
non-invasive bladder volume sensing- eric kurzrock and soheil ghiasi 3/14/2018
-
10:17
highlight #17 experimental validity, specificity, & sensitivity
-
41:18
cambridge neuroscience - dr steve edgley - recurrent problems in spinal-cord and cerebellar circuits